The hypodermic syringes and needles market size has grown steadily in recent years. It will grow from $7.13 billion in 2025 to $7.45 billion in 2026 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to expansion of vaccination programs, growth in hospital and clinic procedures, rising prevalence of chronic diseases requiring injections, increased focus on infection control practices, widespread availability of disposable syringes.
The hypodermic syringes and needles market size is expected to see strong growth in the next few years. It will grow to $9.06 billion in 2030 at a compound annual growth rate (CAGR) of 5%. The growth in the forecast period can be attributed to increasing demand for mass immunization campaigns, rising adoption of safety needles, expansion of home healthcare injection use, growing focus on needle-stick injury prevention, increasing investments in medical consumables manufacturing. Major trends in the forecast period include increasing adoption of safety-engineered syringes and needles, rising demand for disposable injection devices, growing focus on infection prevention solutions, expansion of prefilled and specialty syringe usage, enhanced emphasis on regulatory compliance.
The surge in surgical procedures is anticipated to be a key driver for the growth of the hypodermic syringes and needles market. Surgical procedures, performed by qualified medical professionals, often involve the administration of medications or other substances through injections. Hypodermic syringes and needles are essential tools for delivering controlled and precise doses of these substances. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, minimally invasive procedures increased by 7% in 2023, outpacing the growth rate of surgical procedures by 2%. Hand surgeries such as carpal tunnel, arthritis, and trigger finger totaled 207,887 procedures, a 2% rise from 2022.
Major companies in the hypodermic syringes and needles market are investing in the development of pre-fillable glass syringe systems. These systems are designed for the storage and administration of pharmaceuticals, vaccines, or other injectable substances. For instance, in September 2023, Nipro Corporation launched the D2F Pre-fillable Glass Syringe System - Silicone Oil-Free, addressing the pharmaceutical industry's need for products sensitive to silicone oil. This system aims to meet the increasing demand for injection systems that ensure optimal performance and reduce the risk of interaction-related issues in delivering biotech drugs and other sensitive pharmaceuticals.
In September 2023, Sharps Technology, Inc., a US-based medical products and manufacturing company, acquired InjectEZ from Nephron Pharmaceuticals for an undisclosed amount. Through this acquisition, Sharps seeks to accelerate the commercialization of next-generation copolymer prefillable syringes in the U.S. market and meet multi-year purchase commitments from Nephron and other customers. InjectEZ LLC is a US-based company that provides prefillable copolymer syringes.
Major companies operating in the hypodermic syringes and needles market are Becton Dickinson and Company, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Owen Mumford Ltd., Vygon S.A., Codan Medizinische Geräte GmbH & Co. KG, Vitrex Medical A/S, EXELINT International Co., Helapet Ltd., DeRoyal Industries Inc., Teleflex Incorporated, Gerresheimer AG, SCHOTT AG, Hindustan Syringes & Medical Devices Ltd., Weihai Weigao Group Medical Polymer Co. Ltd., Retractable Technologies Inc., Sarstedt AG & Co. KG, Jiangsu Zhengkang Medical Apparatus Co. Ltd., JECT Corporation.
North America was the largest region in the hypodermic syringes and needles market in 2025. The regions covered in the hypodermic syringes and needles market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hypodermic syringes and needles market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the hypodermic syringes and needles market by increasing costs of imported stainless steel cannulas, medical-grade plastics, sterilization equipment, and automated assembly machinery. Healthcare providers and manufacturers in North America and Europe are most affected due to reliance on imported raw materials and components, while Asia-Pacific faces higher production costs for export-oriented syringe manufacturing. These tariffs are raising unit costs and procurement expenses for healthcare systems. However, they are also supporting domestic production, regional capacity expansion, and investments in localized syringe and needle manufacturing facilities.
The hypodermic syringes and needles market research report is one of a series of new reports that provides hypodermic syringes and needles market statistics, including hypodermic syringes and needles industry global market size, regional shares, competitors with a hypodermic syringes and needles market share, detailed hypodermic syringes and needles market segments, market trends and opportunities, and any further data you may need to thrive in the hypodermic syringes and needles industry. This hypodermic syringes and needles market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Hypodermic syringes and needles are medical devices designed for the injection or withdrawal of bodily fluids or medications. The syringe comprises a barrel, a plunger, and a tip or hub where the needle is attached.
The main types of hypodermic syringes and needles include syringes and needles. Syringes are cylindrical devices equipped with a plunger for injecting or withdrawing bodily fluids. Hypodermic syringes serve various medical purposes, including blood collection through venipuncture. They are available in disposable and reusable models and are applied in diverse medical applications such as blood collection, drug delivery, vaccination, insulin administration, and more. These devices find usage in hospitals, ambulatory surgical centers, diagnostic centers, and various other healthcare end-users.
The hypodermic syringes and needles market revenues includes earned by entities by vacutainer and other consumables, such as pistons, sharps, and sterile containers. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The hypodermic syringes and needles market size is expected to see strong growth in the next few years. It will grow to $9.06 billion in 2030 at a compound annual growth rate (CAGR) of 5%. The growth in the forecast period can be attributed to increasing demand for mass immunization campaigns, rising adoption of safety needles, expansion of home healthcare injection use, growing focus on needle-stick injury prevention, increasing investments in medical consumables manufacturing. Major trends in the forecast period include increasing adoption of safety-engineered syringes and needles, rising demand for disposable injection devices, growing focus on infection prevention solutions, expansion of prefilled and specialty syringe usage, enhanced emphasis on regulatory compliance.
The surge in surgical procedures is anticipated to be a key driver for the growth of the hypodermic syringes and needles market. Surgical procedures, performed by qualified medical professionals, often involve the administration of medications or other substances through injections. Hypodermic syringes and needles are essential tools for delivering controlled and precise doses of these substances. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based non-profit organization, minimally invasive procedures increased by 7% in 2023, outpacing the growth rate of surgical procedures by 2%. Hand surgeries such as carpal tunnel, arthritis, and trigger finger totaled 207,887 procedures, a 2% rise from 2022.
Major companies in the hypodermic syringes and needles market are investing in the development of pre-fillable glass syringe systems. These systems are designed for the storage and administration of pharmaceuticals, vaccines, or other injectable substances. For instance, in September 2023, Nipro Corporation launched the D2F Pre-fillable Glass Syringe System - Silicone Oil-Free, addressing the pharmaceutical industry's need for products sensitive to silicone oil. This system aims to meet the increasing demand for injection systems that ensure optimal performance and reduce the risk of interaction-related issues in delivering biotech drugs and other sensitive pharmaceuticals.
In September 2023, Sharps Technology, Inc., a US-based medical products and manufacturing company, acquired InjectEZ from Nephron Pharmaceuticals for an undisclosed amount. Through this acquisition, Sharps seeks to accelerate the commercialization of next-generation copolymer prefillable syringes in the U.S. market and meet multi-year purchase commitments from Nephron and other customers. InjectEZ LLC is a US-based company that provides prefillable copolymer syringes.
Major companies operating in the hypodermic syringes and needles market are Becton Dickinson and Company, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Owen Mumford Ltd., Vygon S.A., Codan Medizinische Geräte GmbH & Co. KG, Vitrex Medical A/S, EXELINT International Co., Helapet Ltd., DeRoyal Industries Inc., Teleflex Incorporated, Gerresheimer AG, SCHOTT AG, Hindustan Syringes & Medical Devices Ltd., Weihai Weigao Group Medical Polymer Co. Ltd., Retractable Technologies Inc., Sarstedt AG & Co. KG, Jiangsu Zhengkang Medical Apparatus Co. Ltd., JECT Corporation.
North America was the largest region in the hypodermic syringes and needles market in 2025. The regions covered in the hypodermic syringes and needles market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hypodermic syringes and needles market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the hypodermic syringes and needles market by increasing costs of imported stainless steel cannulas, medical-grade plastics, sterilization equipment, and automated assembly machinery. Healthcare providers and manufacturers in North America and Europe are most affected due to reliance on imported raw materials and components, while Asia-Pacific faces higher production costs for export-oriented syringe manufacturing. These tariffs are raising unit costs and procurement expenses for healthcare systems. However, they are also supporting domestic production, regional capacity expansion, and investments in localized syringe and needle manufacturing facilities.
The hypodermic syringes and needles market research report is one of a series of new reports that provides hypodermic syringes and needles market statistics, including hypodermic syringes and needles industry global market size, regional shares, competitors with a hypodermic syringes and needles market share, detailed hypodermic syringes and needles market segments, market trends and opportunities, and any further data you may need to thrive in the hypodermic syringes and needles industry. This hypodermic syringes and needles market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Hypodermic syringes and needles are medical devices designed for the injection or withdrawal of bodily fluids or medications. The syringe comprises a barrel, a plunger, and a tip or hub where the needle is attached.
The main types of hypodermic syringes and needles include syringes and needles. Syringes are cylindrical devices equipped with a plunger for injecting or withdrawing bodily fluids. Hypodermic syringes serve various medical purposes, including blood collection through venipuncture. They are available in disposable and reusable models and are applied in diverse medical applications such as blood collection, drug delivery, vaccination, insulin administration, and more. These devices find usage in hospitals, ambulatory surgical centers, diagnostic centers, and various other healthcare end-users.
The hypodermic syringes and needles market revenues includes earned by entities by vacutainer and other consumables, such as pistons, sharps, and sterile containers. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Hypodermic Syringes and Needles Market Characteristics
3. Hypodermic Syringes and Needles Market Supply Chain Analysis
4. Global Hypodermic Syringes and Needles Market Trends and Strategies
5. Hypodermic Syringes and Needles Market Analysis of End Use Industries
7. Global Hypodermic Syringes and Needles Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Hypodermic Syringes and Needles Total Addressable Market (TAM) Analysis for the Market
9. Hypodermic Syringes and Needles Market Segmentation
10. Hypodermic Syringes and Needles Market Regional and Country Analysis
11. Asia-Pacific Hypodermic Syringes and Needles Market
12. China Hypodermic Syringes and Needles Market
13. India Hypodermic Syringes and Needles Market
14. Japan Hypodermic Syringes and Needles Market
15. Australia Hypodermic Syringes and Needles Market
16. Indonesia Hypodermic Syringes and Needles Market
17. South Korea Hypodermic Syringes and Needles Market
18. Taiwan Hypodermic Syringes and Needles Market
19. South East Asia Hypodermic Syringes and Needles Market
20. Western Europe Hypodermic Syringes and Needles Market
21. UK Hypodermic Syringes and Needles Market
22. Germany Hypodermic Syringes and Needles Market
23. France Hypodermic Syringes and Needles Market
24. Italy Hypodermic Syringes and Needles Market
25. Spain Hypodermic Syringes and Needles Market
26. Eastern Europe Hypodermic Syringes and Needles Market
27. Russia Hypodermic Syringes and Needles Market
28. North America Hypodermic Syringes and Needles Market
29. USA Hypodermic Syringes and Needles Market
30. Canada Hypodermic Syringes and Needles Market
31. South America Hypodermic Syringes and Needles Market
32. Brazil Hypodermic Syringes and Needles Market
33. Middle East Hypodermic Syringes and Needles Market
34. Africa Hypodermic Syringes and Needles Market
36. Hypodermic Syringes and Needles Market Competitive Landscape and Company Profiles
37. Hypodermic Syringes and Needles Market Other Major and Innovative Companies
40. Hypodermic Syringes and Needles Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Hypodermic Syringes And Needles Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses hypodermic syringes and needles market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for hypodermic syringes and needles? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hypodermic syringes and needles market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Syringes; Needles2) By Usability: Disposable; Safety-Engineered Syringes and Needles
3) By Application: Blood Collection; Drug Delivery; Vaccination; Insulin Administration; Other Applications
4) By End-Use: Hospitals; Ambulatory Surgical Centers; Diagnostic Centers; Other End-Uses
Subsegments:
1) By Syringes: Disposable Syringes; Safety Syringes2) By Needles: Standard Needles; Safety Needles; Specialty Needles
Companies Mentioned: Becton Dickinson and Company; B. Braun Melsungen AG; Terumo Corporation; Nipro Corporation; Owen Mumford Ltd.; Vygon S.A.; Codan Medizinische Geräte GmbH & Co. KG; Vitrex Medical A/S; EXELINT International Co.; Helapet Ltd.; DeRoyal Industries Inc.; Teleflex Incorporated; Gerresheimer AG; SCHOTT AG; Hindustan Syringes & Medical Devices Ltd.; Weihai Weigao Group Medical Polymer Co. Ltd.; Retractable Technologies Inc.; Sarstedt AG & Co. KG; Jiangsu Zhengkang Medical Apparatus Co. Ltd.; JECT Corporation
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Hypodermic Syringes and Needles market report include:- Becton Dickinson and Company
- B. Braun Melsungen AG
- Terumo Corporation
- Nipro Corporation
- Owen Mumford Ltd.
- Vygon S.A.
- Codan Medizinische Geräte GmbH & Co. KG
- Vitrex Medical A/S
- EXELINT International Co.
- Helapet Ltd.
- DeRoyal Industries Inc.
- Teleflex Incorporated
- Gerresheimer AG
- SCHOTT AG
- Hindustan Syringes & Medical Devices Ltd.
- Weihai Weigao Group Medical Polymer Co. Ltd.
- Retractable Technologies Inc.
- Sarstedt AG & Co. KG
- Jiangsu Zhengkang Medical Apparatus Co. Ltd.
- JECT Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 7.45 Billion |
| Forecasted Market Value ( USD | $ 9.06 Billion |
| Compound Annual Growth Rate | 5.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
